AstraZeneca settles drug-pricing suit for $103M

AstraZeneca (NYSE: AZN) says it will pay $103 million to settle a class-action suit in the U.S. over its pricing for wholesale drugs, even though it believes its pricing and marketing practices were lawful. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.